Search Results
-
FILTER BY DATEAll Time
-
-
FILTER BY RELEVANCEMost Relevant
-
-
FILTER BY CONTENT TYPEAll Content Types
-
Authorities should focus on India's real health problem: fake and substandard medicines.
In a just-published piece in Tax Notes, AEI economists Kevin Hassett and Alan Viard explain how targeted tax increases on big oil companies pose significant risks to the economy.
Unlocking "unconventional" energy requires unconventional politics, and that's one resource that is genuinely scarce among today's backwards-looking bureaucrats and green interest groups.
With 100,000 patients dying every year from dangerous medicines, it is time to take concrete actions. Establishing a treaty against fake medicines should be the first step.
With fakes of the cancer drug Avastin popping up in U.S. clinics in the past few months, patients are naturally worried about whether their medicines are safe. Considering eighty percent of the ingredients in U.S. medicines come from overseas – mostly from China and India because their products are generally...
While counterfeits must be combated, drugs that are legally but poorly produced, substandard medicines-the subject of today's briefing-tend to get a free pass, even when they kill.
Since the mid-1970s, as a result of the sugar program, the price of sugar in the United States has been almost twice as high as the price of sugar on the world market in most years.
At this AEI event, experts discuss the need for policy reform in the sugar and dairy industries.





